Brief: JenaValve Disagrees With FTC's Decision Against Proposed Edwards Lifesciences Deal
06/08/2025 19:20
Aug 6 (Reuters) - JenaValve: JENAVALVE: DISAGREES WITH FTC'S DECISION AND REMAINS COMMITTED TO COMPLETING ACQUISITION JENAVALVE: INTENDS TO JOIN EDWARDS TO DEFEND CASE IN COURT TO COMPLETE ACQUISITION Source text: ID:nGNX9Czk5d Further company coverage: EW.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals